SCHEMBL11356906

SCHEMBL11356906

COc1ccc(-n2c(=O)[nH][nH]c2=O)cc1OC

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C9 P11712 1/20 0.64
▸ BRD9 Q9H8M2 3/20 0.55
▸ GAA P10253 2/20 0.53
▸ MAPK1 P28482 1/20 0.53
▸ LMNA P02545 3/20 0.50
▸ NTRK1 P04629 1/20 0.50
▸ IGF1R P08069 1/20 0.50
▸ FGFR1 P11362 1/20 0.50
▸ NTRK2 Q16620 1/20 0.50
▸ MAPT P10636 2/20 0.45
▸ KDM4E B2RXH2 2/20 0.45
▸ THRB P10828 1/20 0.45
▸ ALDH1A1 P00352 2/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ GSK3A P49840 1/20 0.44
▸ GSK3B P49841 1/20 0.44
▸ KMT2A Q03164 2/20 0.43
▸ TP53 P04637 1/20 0.43
▸ HPGD P15428 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29779546 0.83 CYP2C9 (0.48) CYP2C9BRD9GAAMAPK1NTRK1
SCHEMBL8187626 0.76 CYP2C9 (0.74) CYP2C9BRD9GAAMAPK1LMNA
SCHEMBL28904576 0.75 ALDH1A1 (0.56) CYP2C9BRD9MAPK1LMNANTRK1
SCHEMBL30615640 0.75 ALDH1A1 (0.56) CYP2C9BRD9MAPK1LMNANTRK1
SCHEMBL9472940 0.75 ATM (0.57) GAALMNANTRK1IGF1RFGFR1
SCHEMBL3030044 0.74 CYP1A2 (0.64) GAANTRK1IGF1RFGFR1NTRK2
SCHEMBL11351513 0.72 G6PD (0.74) CYP2C9BRD9GAAMAPK1LMNA
SCHEMBL10430351 0.70 TUBB4A (0.51) CYP2C9BRD9GAAMAPK1LMNA
SCHEMBL12962502 0.70 LMNA (0.73) CYP2C9BRD9GAAMAPK1LMNA
SCHEMBL7663784 0.70 GAA (0.52) CYP2C9BRD9GAAMAPK1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0033503-A2 Medicaments with cytostatic activity and use of cyclic compounds, in which the heterocyclic N-ring atoms are substituted by several glycidyl groups, in pharmaceutical compositions Henkel Kommanditgesellschaft auf Aktien (DE) 1981-08-12 — — EP disclosed
Send feedback